This assay for the evaluation of p53 overexpression, which usually indicates the presence of gene alterations leading to impaired protein function and nuclear accumulation [14], showed a very high sensitivity (>90%) for the detection of TP53 somatic mutations in medulloblastoma and other malignancies [10,11,15]. The gene discussed is TP53; the disease is medulloblastoma.